Evidence map›Paper›PMID 31708417›Full record

ArticleMolecular cell2020

ATR Protects the Genome against R Loops through a MUS81-Triggered Feedback Loop.

Dominick A Matos, Jia-Min Zhang, Jian Ouyang, Hai Dang Nguyen, Marie-Michelle Genois, Lee Zou

Open access · bronzeAbstract read
In one paragraph

Article in Molecular cell, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 100 papers.

0numbers the graph read from it
0cells of the map it votes in
100citing papers in PubMed
6.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

100 citing papers in PubMed, 144 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Lamin A/C loss promotes R-loop-mediated genomic instability and poor survival in small-cell lung cancer.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  17. Article
  18. Transcription-Replication Conflicts: Unlocking New Frontiers in Cancer.BioEssays : news and reviews in molecular, cellular and developmental biology · 2025
    Review
  19. Article
  20. Article

40 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Dominick A MatosMassachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, MA 02129, USA.
Jia-Min ZhangMassachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, MA 02129, USA.
Jian OuyangMassachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, MA 02129, USA.
Hai Dang NguyenMassachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, MA 02129, USA.
Marie-Michelle GenoisMassachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, MA 02129, USA.
Lee ZouMassachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, MA 02129, USA; Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA. Electronic address: zou.lee@mgh.harvard.edu.
Massachusetts General Hospital · USHarvard University · US

Funding

TRAINING IN CELL STRUCTURE AND FUNCTION IN NEPHROLOGYT32DK007540 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI BROWN, DENNIS, SOBERMAN, ROY · 1986 to 2021
$7.2M
Regulation of the ATR Checkpoint Kinase by DNA DamageR01GM076388 · NIGMS · MASSACHUSETTS GENERAL HOSPITAL · PI ZOU, LEE · 2006 to 2018
$4.3M
Implications of the ATR Checkpoint Kinase in Radiation and Targeted TherapiesR01CA197779 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI ZOU, LEE · 2015 to 2020
$2.4M
Impacts of APOBECs on DNA replication, ATR checkpoint, and cancer therapyR01CA218856 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI ZOU, LEE · 2018 to 2021
$1.5M
Investigating the Novel Function of ATR Checkpoint Kinase in R-Loop ResponsesF31CA210311 · NCI · HARVARD MEDICAL SCHOOL · PI MATOS, DOMINICK AMARAL · 2016 to 2017
$63k
NCI NIH HHS F31 CA210311NCI NIH HHS R01 CA197779NCI NIH HHS R01 CA218856NIDDK NIH HHS T32 DK007540NIGMS NIH HHS R01 GM076388
6 · The paper itself

Abstract

R loops arising during transcription induce genomic instability, but how cells respond to the R loop-associated genomic stress is still poorly understood. Here, we show that cells harboring high levels of R loops rely on the ATR kinase for survival. In response to aberrant R loop accumulation, the ataxia telangiectasia and Rad3-related (ATR)-Chk1 pathway is activated by R loop-induced reversed replication forks. In contrast to the activation of ATR by replication inhibitors, R loop-induced ATR activation requires the MUS81 endonuclease. ATR protects the genome from R loops by suppressing transcription-replication collisions, promoting replication fork recovery, and enforcing a G2/M cell-cycle arrest. Furthermore, ATR prevents excessive cleavage of reversed forks by MUS81, revealing a MUS81-triggered and ATR-mediated feedback loop that fine-tunes MUS81 activity at replication forks. These results suggest that ATR is a key sensor and suppressor of R loop-induced genomic instability, uncovering a signaling circuitry that safeguards the genome against R loops.

Indexed as

Ataxia Telangiectasia Mutated ProteinsCell Cycle ProteinsCheckpoint Kinase 1DNA-Binding ProteinsDNA DamageDNA RepairDNA ReplicationEndonucleasesGenomic InstabilityHeLa CellsHumansPhosphorylationProtein KinasesR-Loop StructuresSignal TransductionAtaxia Telangiectasia Mutated ProteinsATR protein, humanCell Cycle ProteinsCheckpoint Kinase 1DNA-Binding ProteinsEndonucleasesMUS81 protein, humanProtein KinasesATRcheckpointChk1Fork reversalGenomic InstabilityMUS81R loop

Identifiers

PMID31708417
PMCPMC7007873
OpenAlexW2985349530

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.